Danese, S <br/><br/>
New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?  [electronic resource] 

 -  Gastroenterologie clinique et biologique  Jun 2009 
 - S217-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0399-8320 
<br/><br/><label>Standard No.: </label>10.1016/S0399-8320(09)73157-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents--pharmacology<br/>Antibodies, Monoclonal--pharmacology<br/>Biological Products--therapeutic use<br/>Clinical Trials as Topic<br/>Colitis, Ulcerative--therapy<br/>Crohn Disease--therapy<br/>Drug Therapy, Combination<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors